>> Top Page >> Research and Development >> Research Achievements and Future Prospects The results of clinical research at Kurume University involving over 400 patients have demonstrated the usefulness of personalized peptide vaccines (alone or in combination with other medicines) in the treatment of cancer. It is expected that the use of an optimal "peptide set", selected from a relatively large peptide candidate pool, will show good clinical results. It is possible to treat different cancers using different "peptide sets" composed of peptides effective against several kinds of cancers. Basic Research and Clinical Results (Based on clinical results from 400 patients treated at Kurume University) Disease Treatment modality Peptide Tumor Brain Personalized Selected from many peptides derived from human self-antigens. Prostate Personalized+ other medicine Selected from many peptides derived from human self-antigens. Pancreas Personalized+ other medicine Selected from many peptides derived from human self-antigens Stomach (scirrhous) Personalized Selected from many peptides derived from human self-antigens. Colorectal Personalized+ other medicine Selected from many peptides derived from human self-antigens Infectious disease HCV-related chronic hepatitis and other liver diseases Personalized Selected from two or more peptides of HCV Personalized+ other medicine Selected from two or more peptides of HCV Single Single peptide of HCV Single + other medicine Single peptide of HCV